U.S. markets open in 6 hours 47 minutes

ENDRA Life Sciences Inc. (NDRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.1750-0.0200 (-10.26%)
At close: 04:00PM EST
0.1828 +0.01 (+4.46%)
After hours: 07:59PM EST

ENDRA Life Sciences Inc.

3600 Green Court
Suite 350
Ann Arbor, MI 48105-1570
United States
734 335 0468

IndustryDiagnostics & Research
Full Time Employees22

Key Executives

NameTitlePayExercisedYear Born
Mr. Francois MichelonChairman, Pres & CEO511.64kN/A1966
Mr. Michael ThorntonChief Technology Officer358.75kN/A1968
Mr. Renaud Bertrand MalobertiChief Commercial Officer321.53kN/A1969
Dr. Jonathan Behr Ph.D.Co-FounderN/AN/AN/A
Ms. Irina PestrikovaSr. Director of Fin. & Sec.N/AN/A1987
Mr. Steve FreemanHR LeaderN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Corporate Governance

ENDRA Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.